I-Mab Total Liabilities

The latest total liabilities for IMAB is $10M as of June 2025. That compares with $17M in the prior-year period — down 42.0% year over year. Investors often review this figure alongside I-Mab's historical trend and sector peers before judging valuation or financial health.

Over the past year, IMAB's total liabilities moved from $17M to $10M — a 42.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in I-Mab's operating scale or balance-sheet position.

A total liabilities figure of $10M for IMAB is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IMAB's total liabilities ($10M), review year-over-year change from $17M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack I-Mab's total liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.